Stockscreener 앱 받기
4.58
9.31%
-0.47
시간 외 거래:
4.50
-0.08
-1.75%
전일 마감가:
$5.05
열려 있는:
$4.96
하루 거래량:
56,209
Relative Volume:
0.18
시가총액:
$7.26M
수익:
-
순이익/손실:
$-14.58M
주가수익비율:
-3.9826
EPS:
-1.15
순현금흐름:
$-9.80M
1주 성능:
-2.97%
1개월 성능:
-49.11%
6개월 성능:
-66.43%
1년 성능:
-89.59%
1일 변동 폭
$4.4401
$5.1412
1주일 범위
$4.4401
$5.3679
52주 변동 폭
$3.80
$47.80
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
명칭
Acurx Pharmaceuticals Inc
전화
917-533-1469
주소
259 LIBERTY AVENUE, STATEN ISLAND
ACXP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
4.58 | 8.16M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.36 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.01 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.31 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.97 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.33 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Acurx Pharmaceuticals Inc 주식(ACXP)의 최신 뉴스
What technical models suggest about Acurx Pharmaceuticals Inc.’s comebackTrade Signal Summary & Entry Point Strategy Guides - Newser
Strategies to average down on Acurx Pharmaceuticals Inc.Portfolio Performance Summary & Community Trade Idea Sharing - Newser
Acurx signals ongoing cost controls and new trial funding avenues while advancing ibezapolstat clinical program - MSN
Technical Models Detect Momentum Build in Acurx Pharmaceuticals Inc.Market Movement Recap & Real-Time Buy Signal Alerts - thegnnews.com
Technical analysis overview for Acurx Pharmaceuticals Inc. stockSell Signal & Verified Short-Term Trading Plans - Newser
Statistical indicators supporting Acurx Pharmaceuticals Inc.’s strength2025 Market Overview & Daily Price Action Insights - Newser
Published on: 2025-08-20 00:25:12 - Newser
What does recent volatility data suggest for Acurx Pharmaceuticals Inc.Earnings Recap Summary & Growth Focused Investment Plans - Newser
Will Acurx Pharmaceuticals Inc. benefit from macro trendsRate Cut & AI Optimized Trading Strategy Guides - Newser
Acurx Pharmaceuticals Inc. stock momentum explained2025 Macro Impact & Daily Entry Point Trade Alerts - Newser
Will Acurx Pharmaceuticals Inc. continue its uptrendMarket Trend Report & Stock Portfolio Risk Control - Newser
What’s the recovery path for long term holders of Acurx Pharmaceuticals Inc.Portfolio Risk Summary & Entry and Exit Point Strategies - Newser
Will a bounce in Acurx Pharmaceuticals Inc. offer an exitWeekly Gains Report & Community Trade Idea Sharing - Newser
Can volume confirm reversal in Acurx Pharmaceuticals Inc.Trend Reversal & High Accuracy Buy Signal Tips - Newser
Key metrics from Acurx Pharmaceuticals Inc.’s quarterly dataJuly 2025 Weekly Recap & Fast Momentum Entry Tips - Newser
Signal strength of Acurx Pharmaceuticals Inc. stock in tech scannersJuly 2025 Final Week & Free Weekly Chart Analysis and Trade Guides - Newser
How high can Acurx Pharmaceuticals Inc. stock goJuly 2025 Decliners & Breakout Confirmation Alerts - Newser
Real time pattern detection on Acurx Pharmaceuticals Inc. stockMarket Movers & AI Powered Trade Plan Recommendations - Newser
Why Acurx Pharmaceuticals Inc. stock attracts strong analyst attention2025 Major Catalysts & Free Growth Oriented Trading Recommendations - Newser
Published on: 2025-08-19 06:44:47 - Newser
Chart based exit strategy for Acurx Pharmaceuticals Inc.Trade Ideas & Intraday High Probability Setup Alerts - Newser
Can Acurx Pharmaceuticals Inc. rally from current levelsJuly 2025 Gainers & Weekly Sector Rotation Insights - Newser
Acurx Pharmaceuticals (NASDAQ:ACXP) Upgraded by Wall Street Zen to Hold Rating - Defense World
Multi asset correlation models including Acurx Pharmaceuticals Inc.Weekly Trade Report & Weekly Breakout Opportunity Watchlist - Newser
Does Acurx Pharmaceuticals Inc. fit your quant trading modelQuarterly Market Summary & Reliable Price Action Trade Plans - Newser
Tools to assess Acurx Pharmaceuticals Inc.’s risk profile2025 EndofYear Setup & Precise Swing Trade Alerts - Newser
Published on: 2025-08-16 01:02:27 - Newser
Intraday pattern recognizer results for Acurx Pharmaceuticals Inc.2025 Trade Ideas & Real-Time Stock Movement Alerts - Newser
Acurx Pharmaceuticals Inc (ACXP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Acurx Pharmaceuticals Inc 주식 (ACXP) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Sailer Carl | Director |
Jan 06 '25 |
Buy |
1.01 |
24,631 |
25,000 |
137,183 |
| LUCI DAVID P | President and CEO |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,097,458 |
| Donohue James J. | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
22,352 |
| DELUCCIA ROBERT J | Director |
Jan 06 '25 |
Buy |
1.01 |
49,261 |
50,000 |
1,010,196 |
| DEAN JACK H | Director |
Jan 06 '25 |
Buy |
1.01 |
9,852 |
10,000 |
21,776 |
2.44%
0.09%
자본화:
|
볼륨(24시간):